Artal Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $89.7M | Sell |
|
|||||
2024
Q1 | $122M | Buy |
|
|||||
2023
Q4 | $64.4M | Buy |
|
|||||
2023
Q3 | $25.1M | Hold |
|
|||||
2023
Q2 | $41.5M | Hold |
|
|||||
2023
Q1 | $53.5M | Sell |
|
|||||
2022
Q4 | $49.9M | Buy |
|
|||||
2022
Q3 | $32.7M | Buy |
|
|||||
2022
Q2 | $19.7M | Hold |
|
|||||
2022
Q1 | $42.3M | Hold |
|
|||||
2021
Q4 | $63.5M | Buy |
|
|||||
2021
Q3 | $23.5M | Buy |
|
|||||
2021
Q2 | $12.1M | Hold |
|
|||||
2021
Q1 | $9.71M | Hold |
|
|||||
2020
Q4 | $15.5M | Hold |
|
|||||
2020
Q3 | $8.08M | Buy |
|